Factor IX Inhibition in Thrombosis Prevention (The FIXIT Trial)

PHASE2CompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

January 31, 2005

Study Completion Date

April 30, 2006

Conditions
Venous ThromboembolismEmbolism and ThrombosisHip Fractures
Interventions
DRUG

TTP889

Trial Locations (21)

2400

H:S Bispebjerg Hospital, Copenhagen

2609

Skyehuset Innlandet HF, Lillehammer

2730

KAS Herlev, Herlev

2819

Skyehuset Innlandet HF, Gjøvik

2900

Amtsygehuset i Gentofte, Hellerup

2970

Horsholm Hospital, Hørsholm

3116

Halfdan Wilhelmsens Alle 17, Tønsberg

6026

Orthopedics, Alesund Sykehus, Ålesund

8600

Silkeborg Hospital, Silkeborg

9000

AAlborg Hospital, Aalborg

9640

Ortopaedkirurgisk Klinik, Farso, Farsø

370 87

Nemocnice Ceske Budejovice, Urazove oddeleni, České Budějovice

708 52

FN s Poliklinikou Ostrava, Traumatologicke Centrum, Ostrava-Poruba

150 06

FN Motol, Ortopedicka Klinicka UK 2.LF a FN Notol, Prague

180 81

FN Na Bulovce, Ortopedicka Klinika IPVZ a 1.LF UK ORT, Budinova 2, Prague

128 08

VFN, I. Chirurgicka klinika, Praha-2

416 85

Ortoped Kliniken, Sahlgrenska Universitetssjukhus, Ostra, Gothenburg

442 83

Ortopedsektionen, Kirurgkliniken, Kungalvs Sjukhus, Kungälv

431 80

Ortoped kliniken, Sahlgrenska Universitetssjukhus, Mölndal

451 80

Ortoped kliniken, NU-sjukvarden, Udevalla Sjukhus, Udevalla

432 81

Ortoped kliniken, Sjukhuset i Varberg, Varberg

Sponsors

Lead Sponsor

All Listed Sponsors
lead

vTv Therapeutics

INDUSTRY

NCT00119457 - Factor IX Inhibition in Thrombosis Prevention (The FIXIT Trial) | Biotech Hunter | Biotech Hunter